TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2013

Randomized phase II, double-blind, placebo-controlled study of exemestane with or without entinostat in postmenopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer progressing on treatment with a nonsteroidal aromatase inhibitor.

Denise A Yardley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.